NERVGEN PHARMA CORP. (NGEN) reporting calendar
NERVGEN PHARMA CORP. files periodic reports with the SEC as NGEN on Nasdaq. Atlas tracks 1 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 40-F
- Period ended
- 31 Dec 2025
- Filed
- 31 Mar 2026
- Reports on record
- 1
Open NGEN market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 40-F | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001104659-26-037357 |
Source: SEC EDGAR company submissions for CIK 0001751912. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.